Lung cancer markers, including carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), squamous cell carcinoma (SCC) antigen, and cytokeratin 19 (CK19), have been generally utilized to identify malignant and nonmalignant pleural effusions [4-7]. The gene discussed is KRT19; the disease is Pleural effusion.